Literature DB >> 32199467

Immunotherapy in lung cancer: effective for patients with poor performance status?

Joao V Alessi1, Mark M Awad2.   

Abstract

Entities:  

Year:  2020        PMID： 32199467     DOI： 10.1016/S2213-2600(20)30107-7

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  2 in total

1.  Immune Subtypes and Immune Landscape Analysis of Endometrial Carcinoma.

Authors:  Leilei Liang; Yunshu Zhu; Jian Li; Jia Zeng; Guangwen Yuan; Lingying Wu
Journal:  J Immunol       Date:  2022-09-12       Impact factor: 5.426

2.  Association of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy.

Authors:  Kartik Sehgal; Ritu R Gill; Page Widick; Poorva Bindal; Danielle C McDonald; Meghan Shea; Deepa Rangachari; Daniel B Costa
Journal:  JAMA Netw Open       Date:  2021-02-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.